<- Go home

Added to YB: 2021-01-21

Pitch date: 2021-01-21

CPRX [bullish]

Catalyst Pharmaceuticals, Inc.

+762.74%

current return

Author Info

No bio for this author

Company Info

Catalyst Pharmaceuticals, Inc. operates as a biopharmaceutical company engaged in developing and commercializing novel medicines for patients living with rare diseases.

Market Cap

$3.9B

Pitch Price

$3.65

Price Target

N/A

Dividend

N/A

EV/EBITDA

10.13

P/E

18.20

EV/Sales

5.20

Sector

Biotechnology

Category

N/A

Show full summary:
CATALYST PHARMACEUTICALS INC CPRX

A summary for this pitch has not been created yet.

Read full article (0 min)